13 hasil untuk "Dominik Lock"
Menampilkan 1–13 · 1,36 detik · RSS
-
Artikel Jurnal Teks lengkap
FAS-Based Cell Depletion Facilitates the Selective Isolation of Mouse Induced Pluripotent Stem Cells
Cellular reprogramming of somatic cells into induced pluripotent stem cells (iPSC) opens up new avenues for basic research and regenerative medicine. However, the low efficiency of the procedure remains a major limitation. To identify iPSC, many studies to date relied on the activation of…
Juga tersedia di: DOAJ
-
Artikel Jurnal
Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma
The prognosis for patients with metastatic melanoma is poor and treatment options are limited. Genetically-engineered T cell therapy targeting chondroitin sulfate proteoglycan 4 (CSPG4), however, represents a promising treatment option, especially as both primary melanoma cells as well as…
-
Artikel Jurnal
CD137+CD154− Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures
Regulatory T cells (Tregs) are an attractive therapeutic tool for several different immune pathologies. Therapeutic Treg application often requires prolonged in vitro culture to generate sufficient Treg numbers or to optimize their functionality, e.g., via genetic engineering of their antigen…
-
Artikel Jurnal
A novel pseudotype derived of the canine distemper virus for adapter-mediated lentiviral transduction in vivo
Targeted cell entry with lentiviral vectors (LVs) is one approach to enable efficient and specific gene delivery in the context of immunotherapies, such as chimeric antigen receptor (CAR)-T cell therapy. We have recently shown the generation of CAR-T products with varying CD4:CD8 ratios with our…
-
Artikel Jurnal
CAR’TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment
Acute myeloid leukemia (AML), a fast-progressing hematological malignancy affecting myeloid cells, is typically treated with chemotherapy or hematopoietic stem cell transplantation. However, approximately half of the patients face relapses and 5-year survival rates are poor. With the goal to…
-
Artikel Jurnal
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells
Recently, a rare type of relapse was reported upon treating a B cell acute lymphoblastic leukemia (B-ALL) patient with anti-CD19 chimeric antigen receptor (CAR)-T cells caused by unintentional transduction of residual malignant B cells (CAR-B cells). We show that anti-CD19 and anti-CD20 CARs are…
-
Artikel Jurnal
Automated generation of gene-edited CAR T cells at clinical scale
The potential of adoptive cell therapy can be extended when combined with genome editing. However, variation in the quality of the starting material and the different manufacturing steps are associated with production failure and product contamination. Here, we present an automated T cell…
-
Artikel Jurnal
Automated, scaled, transposon-based production of CAR T cells
Background There is an increasing demand for chimeric antigen receptor (CAR) T cell products from patients and care givers. Here, we established an automated manufacturing process for CAR T cells on the CliniMACS Prodigy platform that is scaled to provide therapeutic doses and achieves…
-
Artikel Jurnal
Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy
Acute myeloid leukemia (AML) is a heterogeneous malignancy that requires further therapeutic improvement, especially for the elderly and for subgroups with poor prognosis. A recently discovered T cell receptor (TCR) targeting mutant nucleophosmin 1 (ΔNPM1) presents an attractive option for the…
-
Artikel Jurnal
Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells
Solid tumors consist of malignant and nonmalignant cells that together create the local tumor microenvironment (TME). Additionally, the TME is characterized by the expression of numerous soluble factors such as TGF-β. TGF-β plays an important role in the TME by suppressing T cell effector function…
-
Artikel Jurnal
Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma
There is an unmet clinical need to identify therapeutic options for the treatment of pancreatic cancer (PDAC). Here the authors present a systematic screening approach for the identification of potential PDAC cell surface target candidates for CAR-T cell based immunotherapy, followed by their…
-
Artikel Jurnal
Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting
Chimeric antigen receptor (CAR)-T therapy holds great promise to sustainably improve cancer treatment. However, currently, a broad applicability of CAR-T cell therapies is hampered by limited CAR-T cell versatility and tractability and the lack of exclusive target antigens to discriminate cancerous…